Advertisement

Olibanum – Ruxiang

  • Hildebert Wagner
  • Stefanie Püls
  • Talee Barghouti
  • Anton Staudinger
  • Dieter Melchart
Chapter

Abstract

References

  1. 1.
    Pharmacopoeia of the People’s Republic of China, English Edition Vol. I, People’s Medical Publishing House, Beijing (2010)Google Scholar
  2. 2.
    Hager H, Blaschek W, Ebel S, Hackenthal E, HagerROM 2003: Hagers Handbuch der Drogen und Arzneistoffe, 3. Version, Springer (2003)Google Scholar
  3. 3.
    Woolley CL1, Suhail MM, Smith BL, Boren KE, Taylor LC, Schreuder MF, Chai JK, Casabianca H, Haq S, Lin HK, Al-Shahri AA, Al-Hatmi S, Young DG, Chemical differentiation of Boswellia sacra and Boswellia carterii essential oils by gas chromatography and chiral gas chromatography-mass spectrometry, J. Chromatogr. 1261, 158-163 (2012)Google Scholar
  4. 4.
    Mathe C, Culioli G, Archier P, Vieillescazes C, High-Performance Liquid Chromatographic Analysis of Triterpenoids in Commercial Frankincense, Chromatographia 60(9-10), 493-499 (2004)CrossRefGoogle Scholar
  5. 5.
    Zhang ZZ, An Illustrated Chinese Materia Medica in Hong Kong, School of Chinese Medicine/Hong Kong Baptist University, Hong Kong (2004)Google Scholar
  6. 6.
    Paul M, Brüning G, Bergmann J, Jauch J, A Thin-layer Chromatography Method for the Identification of Three Different Olibanum Resins (Boswellia serrata, Boswellia papyrifery and Boswellia carterii, respectively, Boswellia sacra), Phytochem. Anal. 23(2), 184-189 (2012)CrossRefPubMedGoogle Scholar
  7. 7.
    Zhang Y, Ning Z, Lu C, Zhao C, Zhao S, Wang J, Liu B, Xu X, Liu Y, Triterpenoid resinous metabolites from the genus Boswellia: pharmacological activities and potential species-identifying properties, Chem. Cent. J. 7(1), 153 (2013)CrossRefGoogle Scholar
  8. 8.
    Ammon HPT, Indian Boswellia oder die Renaissance des Olibanums in der westlichen Welt, Z. Phytother. 34, 70-73 (2013)CrossRefGoogle Scholar
  9. 9.
    Hempen C-H, Fischer T, A Materia Medica for Chinese Medicine, English Edition, Elsevier GmbH, Urban & Fischer, Munich (2009)Google Scholar
  10. 10.
    Geng J, Huang W, Ren T, Ma X, Materia Medica der Chinesischen Arzneimitteltherapie (Bd. 2: Praxis der Chinesischen Arzneimitteltherapie), Verlag für Ganzheitliche Medizin Dr. Erich Wühr GmbH, Kötzting/Bayer. Wald (1993)Google Scholar
  11. 11.
    Ren J, Wang YG, Wang AG, Wu LQ, Zhang HJ, Wang WJ, Su YL, Qin HL, Cembranoids from the Gum Resin of Boswellia carterii as Potential Antiulcerative Colitis Agents, J. Nat. Prod. 78(10), 2322-2331 (2015)CrossRefPubMedGoogle Scholar
  12. 12.
    Wang YG, Ren J, Wang AG, Yang JB, Ji TF, Ma QG, Tian J, Su YL, Hepatoprotective Prenylaromadendrane-Type Diterpenes from the Gum Resin of Boswellia carterii, J. Nat. Prod. 76(11), 2074-2079 (2013)CrossRefPubMedGoogle Scholar
  13. 13.
    Banno N, Akihisa T, Yasukawa K, Tokuda H, Tabata K, Nakamura Y, Nishimura R, Kimura Y, Suzuki T, Anti-inflammatory activities of the triterpene acids from the resin of Boswellia carteri, J. Ethnopharmacol. 107(2), 249-253 (2006)CrossRefPubMedGoogle Scholar
  14. 14.
    Yoshikawa M, Morikawa T, Oominami H, Matsuda H, Absolute Stereostructures of Olibanumols A, B, C, H, I and J from Olibanum, Gum-Resin of Boswellia carterii, and Inhibitors of Nitric Oxide Production in Lipopolysaccharide-Activated Mouse Peritoneal Macrophages, Chem. Pharm. Bull. 57(9), 957-964 (2009)CrossRefPubMedGoogle Scholar
  15. 15.
    Büchele B, Zugmaier W, Simmet T, Analysis of pentacyclic triterpenic acids from frankincense gum resins and related phytopharmaceuticals by high-performance liquid chromatography. Identification of lupeolic acid, a novel pentacyclic triterpene, J. Chromatogr. B 791(1-2), 21-30 (2003)CrossRefGoogle Scholar
  16. 16.
    Badria FA, Mikhaeil BR, Maatooq GT, Amer MMA, Immunomodulatory Triterpenoids from the Oleogum Resin of Boswellia carterii Birdwood, Z. Naturforsch. C 58(7-8), 505-516 (2003)CrossRefPubMedGoogle Scholar
  17. 17.
    Morikawa T, Oominami H, Matsuda H, Yoshikawa M, New terpenoids, olibanumols D-G, from traditional Egyptian medicine olibanum, the gum-resin of Boswellia carterii, J. Nat. Med. 65(1), 129-134 (2011)CrossRefPubMedGoogle Scholar
  18. 18.
    Wang F, Li ZL, Cui HH, Hua HM, Jing YK, Liang SW, Two new triterpenoids from the resin of Boswellia carterii, J. Asian Nat. Prod. Res. 13(3), 193-197 (2011)CrossRefPubMedGoogle Scholar
  19. 19.
    Akihisa T, Tabata K, Banno N, Tokuda H, Nishihara R, Nakamura Y, Kimura Y, Yasukawa K, Suzuki T, Cancer Chemopreventive Effects and Cytotoxic Activities of the Triterpene Acids from the Resin of Boswellia carteri, Biol. Pharm. Bull. 29(9), 1976-1979 (2006)CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Hildebert Wagner
    • 1
  • Stefanie Püls
    • 2
  • Talee Barghouti
    • 2
  • Anton Staudinger
    • 3
  • Dieter Melchart
    • 4
  1. 1.LMU Munich Center of Pharma ResearchMunichGermany
  2. 2.Center of Pharma ResearchLMU Munich Center of Pharma ResearchMunichGermany
  3. 3.TCM-Klinik Bad KötztingBad KötztingGermany
  4. 4.Klinikum rechts der IsarKompetenzzentrum KomplementärmedMünchenGermany

Personalised recommendations